
CNS Brainstorm Episode 48 "Pediatric NF1 Therapeutics" with guest Bonnie Kaur, MD
Child Neurology Society's Brainstorm
00:00
Mirdametinib approval and outcomes
Bonnie Kaur details mirdametinib's 2025 approval, response rates, median tumor reduction, and similar side effects profile.
Play episode from 06:32
Transcript


